1 Study Coverage
1.1 Herpes Simplex Virus (HSV) Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 GEN-003
1.2.3 VCL-HB01
1.2.4 HSV529
1.2.5 Others
1.3 Market by Application
1.3.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 HSV-1 (Oral Herpes)
1.3.3 HSV-2 (Genital Herpes)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region
2.4.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Herpes Simplex Virus (HSV) Vaccines by Region (2023-2028)
2.5 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region
2.5.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2017-2022)
2.5.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Manufacturers
3.1.1 Global Top Herpes Simplex Virus (HSV) Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Herpes Simplex Virus (HSV) Vaccines in 2021
3.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturers
3.2.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Herpes Simplex Virus (HSV) Vaccines Revenue in 2021
3.3 Global Herpes Simplex Virus (HSV) Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Herpes Simplex Virus (HSV) Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type
4.1.1 Global Herpes Simplex Virus (HSV) Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Herpes Simplex Virus (HSV) Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type
4.2.1 Global Herpes Simplex Virus (HSV) Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Herpes Simplex Virus (HSV) Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Type
4.3.1 Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2017-2022)
4.3.2 Global Herpes Simplex Virus (HSV) Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Application
5.1.1 Global Herpes Simplex Virus (HSV) Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Herpes Simplex Virus (HSV) Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application
5.2.1 Global Herpes Simplex Virus (HSV) Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Herpes Simplex Virus (HSV) Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Application
5.3.1 Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2017-2022)
5.3.2 Global Herpes Simplex Virus (HSV) Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Herpes Simplex Virus (HSV) Vaccines Market Size by Type
6.1.1 North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2028)
6.1.2 North America Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2028)
6.2 North America Herpes Simplex Virus (HSV) Vaccines Market Size by Application
6.2.1 North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2028)
6.2.2 North America Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2028)
6.3 North America Herpes Simplex Virus (HSV) Vaccines Market Size by Country
6.3.1 North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2028)
6.3.2 North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Type
7.1.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2028)
7.1.2 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2028)
7.2 Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Application
7.2.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2028)
7.2.2 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2028)
7.3 Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Country
7.3.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2028)
7.3.2 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Size by Type
8.1.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Size by Application
8.2.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Size by Region
8.3.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Herpes Simplex Virus (HSV) Vaccines Market Size by Type
9.1.1 Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2028)
9.2 Latin America Herpes Simplex Virus (HSV) Vaccines Market Size by Application
9.2.1 Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2028)
9.3 Latin America Herpes Simplex Virus (HSV) Vaccines Market Size by Country
9.3.1 Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size by Type
10.1.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size by Application
10.2.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size by Country
10.3.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Herpes Simplex Virus (HSV) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Recent Developments
11.3 Genocea Biosciences
11.3.1 Genocea Biosciences Corporation Information
11.3.2 Genocea Biosciences Overview
11.3.3 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Genocea Biosciences Recent Developments
11.4 Vical
11.4.1 Vical Corporation Information
11.4.2 Vical Overview
11.4.3 Vical Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Vical Herpes Simplex Virus (HSV) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Vical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Herpes Simplex Virus (HSV) Vaccines Industry Chain Analysis
12.2 Herpes Simplex Virus (HSV) Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Herpes Simplex Virus (HSV) Vaccines Production Mode & Process
12.4 Herpes Simplex Virus (HSV) Vaccines Sales and Marketing
12.4.1 Herpes Simplex Virus (HSV) Vaccines Sales Channels
12.4.2 Herpes Simplex Virus (HSV) Vaccines Distributors
12.5 Herpes Simplex Virus (HSV) Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Herpes Simplex Virus (HSV) Vaccines Industry Trends
13.2 Herpes Simplex Virus (HSV) Vaccines Market Drivers
13.3 Herpes Simplex Virus (HSV) Vaccines Market Challenges
13.4 Herpes Simplex Virus (HSV) Vaccines Market Restraints
14 Key Findings in The Global Herpes Simplex Virus (HSV) Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of GEN-003
Table 3. Major Manufacturers of VCL-HB01
Table 4. Major Manufacturers of HSV529
Table 5. Major Manufacturers of Others
Table 6. Global Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2017-2022) & (K Units)
Table 9. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2017-2022)
Table 10. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2023-2028) & (K Units)
Table 11. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2023-2028)
Table 12. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2017-2022)
Table 14. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2023-2028)
Table 16. Global Herpes Simplex Virus (HSV) Vaccines Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Manufacturers (2017-2022)
Table 18. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Manufacturers (2017-2022)
Table 20. Herpes Simplex Virus (HSV) Vaccines Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global Herpes Simplex Virus (HSV) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Herpes Simplex Virus (HSV) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus (HSV) Vaccines as of 2021)
Table 23. Herpes Simplex Virus (HSV) Vaccines Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Herpes Simplex Virus (HSV) Vaccines Product Offered
Table 25. Date of Manufacturers Enter into Herpes Simplex Virus (HSV) Vaccines Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)
Table 28. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2023-2028) & (K Units)
Table 29. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Type (2017-2022)
Table 30. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Type (2023-2028)
Table 31. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Type (2017-2022)
Table 34. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Type (2023-2028)
Table 35. Herpes Simplex Virus (HSV) Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 36. Global Herpes Simplex Virus (HSV) Vaccines Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)
Table 38. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2023-2028) & (K Units)
Table 39. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Application (2017-2022)
Table 40. Global Herpes Simplex Virus (HSV) Vaccines Sales Share by Application (2023-2028)
Table 41. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Application (2017-2022)
Table 44. Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Application (2023-2028)
Table 45. Herpes Simplex Virus (HSV) Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 46. Global Herpes Simplex Virus (HSV) Vaccines Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)
Table 48. North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2023-2028) & (K Units)
Table 49. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)
Table 52. North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2023-2028) & (K Units)
Table 53. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022) & (K Units)
Table 56. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2023-2028) & (K Units)
Table 57. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)
Table 60. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2023-2028) & (K Units)
Table 61. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)
Table 64. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2023-2028) & (K Units)
Table 65. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022) & (K Units)
Table 68. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2023-2028) & (K Units)
Table 69. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 107. Sanofi Corporation Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Sanofi Herpes Simplex Virus (HSV) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. GlaxoSmithKline Corporation Information
Table 113. GlaxoSmithKline Description and Major Businesses
Table 114. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. GlaxoSmithKline Recent Developments
Table 117. Genocea Biosciences Corporation Information
Table 118. Genocea Biosciences Description and Major Businesses
Table 119. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Genocea Biosciences Recent Developments
Table 122. Vical Corporation Information
Table 123. Vical Description and Major Businesses
Table 124. Vical Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Vical Herpes Simplex Virus (HSV) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Vical Recent Developments
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Herpes Simplex Virus (HSV) Vaccines Distributors List
Table 130. Herpes Simplex Virus (HSV) Vaccines Customers List
Table 131. Herpes Simplex Virus (HSV) Vaccines Market Trends
Table 132. Herpes Simplex Virus (HSV) Vaccines Market Drivers
Table 133. Herpes Simplex Virus (HSV) Vaccines Market Challenges
Table 134. Herpes Simplex Virus (HSV) Vaccines Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Herpes Simplex Virus (HSV) Vaccines Product Picture
Figure 3. Global Herpes Simplex Virus (HSV) Vaccines Market Share by Type in 2021 & 2028
Figure 3. GEN-003 Product Picture
Figure 4. VCL-HB01 Product Picture
Figure 5. HSV529 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Herpes Simplex Virus (HSV) Vaccines Market Share by Application in 2021 & 2028
Figure 8. HSV-1 (Oral Herpes)
Figure 9. HSV-2 (Genital Herpes)
Figure 10. Herpes Simplex Virus (HSV) Vaccines Report Years Considered
Figure 11. Global Herpes Simplex Virus (HSV) Vaccines Sales 2017-2028 (K Units)
Figure 12. Global Herpes Simplex Virus (HSV) Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Herpes Simplex Virus (HSV) Vaccines Revenue 2017-2028 (US$ Million)
Figure 14. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2017-2022)
Figure 16. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2023-2028)
Figure 17. North America Herpes Simplex Virus (HSV) Vaccines Sales YoY (2017-2028) & (K Units)
Figure 18. North America Herpes Simplex Virus (HSV) Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Herpes Simplex Virus (HSV) Vaccines Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Herpes Simplex Virus (HSV) Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Herpes Simplex Virus (HSV) Vaccines Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Herpes Simplex Virus (HSV) Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Herpes Simplex Virus (HSV) Vaccines in the World: Market Share by Herpes Simplex Virus (HSV) Vaccines Revenue in 2021
Figure 29. Global Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2028)
Figure 31. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2017-2028)
Figure 32. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2028)
Figure 33. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2017-2028)
Figure 34. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2028)
Figure 35. North America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2017-2028)
Figure 36. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2028)
Figure 37. North America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2017-2028)
Figure 38. North America Herpes Simplex Virus (HSV) Vaccines Sales Share by Country (2017-2028)
Figure 39. North America Herpes Simplex Virus (HSV) Vaccines Revenue Share by Country (2017-2028)
Figure 40. U.S. Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2028)
Figure 43. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2017-2028)
Figure 44. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2028)
Figure 45. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2017-2028)
Figure 46. Europe Herpes Simplex Virus (HSV) Vaccines Sales Share by Country (2017-2028)
Figure 47. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Share by Country (2017-2028)
Figure 48. Germany Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 49. France Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue Share by Region (2017-2028)
Figure 59. China Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 62. India Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2028)
Figure 70. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2028)
Figure 72. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Herpes Simplex Virus (HSV) Vaccines Sales Share by Country (2017-2028)
Figure 74. Latin America Herpes Simplex Virus (HSV) Vaccines Revenue Share by Country (2017-2028)
Figure 75. Mexico Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue Share by Country (2017-2028)
Figure 84. Turkey Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Herpes Simplex Virus (HSV) Vaccines Revenue (2017-2028) & (US$ Million)
Figure 87. Herpes Simplex Virus (HSV) Vaccines Value Chain
Figure 88. Herpes Simplex Virus (HSV) Vaccines Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
